Dr. Michael Joseph Dattoli , MD
Specialist • Sarasota, FL
2803 Fruitville Rd, Suite 1
Sarasota, FL 342375344
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 31, 2006; this date does not establish years in practice.
-
Published CMS data list 11,777 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 — Injection, denosumab, 1 mg: 5,280 service units.
- G6015 — Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session: 1,310 service units.
- G6017 — Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment: 1,308 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 27 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,879 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Dutasteride — 436 prescription fills, including refills.
- Tamsulosin Hcl — 411 prescription fills, including refills.
- Cabergoline — 302 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: 1,487. Middle half: 453 to 3,647.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 26,257 in 2020 to 11,777 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2803 Fruitville Rd
Suite 1
Sarasota, FL 342375344
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Icahn School Of Medicine At Mount Sinai
1985
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
497 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $1,427,880 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $1,127,249 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,333 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,975,972 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,028.09 across 50 records.
By nature of payment
- Food and Beverage: $1,028.09 across 50 records.
Reporting-company totals (3 largest of 14)
- Dendreon Pharmaceuticals LLC: $193.38 across 8 records.
- Janssen Pharmaceuticals, Inc: $165.68 across 12 records.
- Pfizer Inc.: $164.24 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
41 years (graduated 1985)
CMS Doctors and Clinicians data list 1985 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Dattoli has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Dattoli as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Sarasota and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: 1,487. Middle half: 453 to 3,647.
Too few clinicians listed under Specialist in Sarasota have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: $129,953. Middle half: $43,519 to $280,097.
Too few clinicians listed under Specialist in Sarasota have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: $96,632. Middle half: $32,296 to $209,932.
Too few clinicians listed under Specialist in Sarasota have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Specialist in Florida (2024, 508 clinicians with data). Median for this group: 602. Middle half: 126 to 2,340.
Too few clinicians listed under Specialist in Sarasota have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Florida (2024, 508 clinicians with data). Median for this group: $35,772. Middle half: $2,466 to $359,998.
Too few clinicians listed under Specialist in Sarasota have Medicare Part D data for 2024 to compare.
55 active clinicians are listed under Specialist with a practice address in Sarasota, FL (2,695 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Sarasota
3.6% of these 55 clinicians have the CMS telehealth indicator.
12.7% of these 55 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 55% from 26,257 in 2020 to 11,777 in 2024.
- 2020: 26,257
- 2021: 23,932
- 2022: 9,825
- 2023: 12,586
- 2024: 11,777
-
Medicare-allowed amount
Medicare-allowed amount decreased 40% from $2,390,028 in 2020 to $1,427,880 in 2024.
- 2020: $2,390,028
- 2021: $2,583,427
- 2022: $1,033,162
- 2023: $1,356,337
- 2024: $1,427,880
-
Paid by Medicare
Paid by Medicare decreased 41% from $1,902,252 in 2020 to $1,127,249 in 2024.
- 2020: $1,902,252
- 2021: $2,058,302
- 2022: $811,483
- 2023: $1,068,514
- 2024: $1,127,249
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 40% from 4,816 in 2020 to 2,879 in 2024.
- 2020: 4,816
- 2021: 4,437
- 2022: 3,069
- 2023: 2,546
- 2024: 2,879
-
30-day fills
30-day fills decreased 38% from 10,235 in 2020 to 6,333 in 2024.
- 2020: 10,235
- 2021: 9,531
- 2022: 6,847
- 2023: 5,789
- 2024: 6,333
-
Part D drug cost
Part D drug cost increased 69% from $1,172,400 in 2020 to $1,975,972 in 2024.
- 2020: $1,172,400
- 2021: $1,145,500
- 2022: $917,173
- 2023: $928,415
- 2024: $1,975,972
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $164.73 in 2021 to $1,028.09 in 2025.
- 2021: $164.73
- 2022: $295.34
- 2023: $1,007.89
- 2024: $938.78
- 2025: $1,028.09
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 50 records totaling $1,028.09.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.75 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.55 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $31.48 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Xofigo | General | $28.38 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
SpaceOAR VUE System - 10mL | General | $27.82 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $27.80 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $27.75 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $27.69 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $26.80 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $26.54 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $26.16 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $25.85 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $25.82 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $25.39 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.83 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $24.45 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $24.08 |
| Bard Peripheral Vascular, Inc. |
Food and Beverage
In-kind items and services
|
Model 200 TheraSeed Palladium-103 in ReadyLink | General | $23.87 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.84 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $23.33 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $23.28 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $23.15 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $21.88 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $21.42 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
ELIGARD | General | $20.67 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
5,280 | 29 | $79.00 | $25.47 |
|
G6015
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
|
1,310 | 47 | $1174.00 | $330.98 |
|
G6017
Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment
|
1,308 | 47 | $316.00 | $75.05 |
|
77300
Calculation of radiation therapy dose
|
628 | 41 | $222.00 | $63.09 |
|
77290
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved
|
423 | 385 | $1489.00 | $414.65 |
|
76872
Ultrasound scan of pelvic region through rectum
|
410 | 370 | $462.00 | $127.36 |
|
93980
Complete ultrasound of penis artery and vein blood flow
|
409 | 369 | $388.00 | $109.30 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
388 | 345 | $609.00 | $172.90 |
|
77427
Radiation treatment management, 5 treatment sessions
|
258 | 49 | $656.00 | $187.22 |
|
77336
Continuing radiation therapy consultation per week
|
250 | 45 | $288.29 | $83.88 |
|
J3315
Injection, triptorelin pamoate, 3.75 mg
|
157 | 26 | $1309.00 | $433.88 |
|
36415
Insertion of needle into vein for collection of blood sample
|
115 | 99 | $10.00 | $8.65 |
|
77338
Design and construction of radiation treatment device for high precision radiation therapy
|
110 | 41 | $1553.00 | $447.64 |
|
71250
Ct scan of chest without contrast
|
108 | 78 | $461.00 | $89.13 |
|
74176
Ct scan of abdomen and pelvis without contrast
|
108 | 77 | $637.00 | $168.05 |
|
77014
Ct guidance for insertion of radiation therapy fields
|
104 | 16 | $402.00 | $113.81 |
|
77334
Design and construction of complex radiation treatment device
|
101 | 43 | $417.00 | $119.78 |
|
96372
Injection of drug or substance under skin or into muscle
|
42 | 23 | $48.00 | $13.77 |
|
77263
Complex radiation therapy planning
|
41 | 38 | $583.00 | $165.21 |
|
77470
Special radiation treatment
|
40 | 37 | $473.00 | $137.58 |
|
77293
Obtaining respiratory data needed to develop the optimal radiation treatment
|
37 | 37 | $1661.35 | $384.31 |
|
77301
High precision radiation therapy planning
|
37 | 37 | $6070.00 | $1734.33 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
28 | 26 | $113.00 | $33.49 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
27 | 27 | $752.00 | $217.42 |
|
77078
Ct scan for measuring calcium and other minerals in bone
|
26 | 26 | $328.00 | $90.17 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Dutasteride | Dutasteride | 436 | 29,246 | $12,642.13 | 127 |
| Tamsulosin Hcl | Tamsulosin Hcl | 411 | 30,871 | $8,502.63 | 150 |
| Cabergoline | Cabergoline | 302 | 17,343 | $28,758.14 | 73 |
| Pentoxifylline | Pentoxifylline | 235 | 18,064 | $10,371.21 | 98 |
| Metformin Hcl | Metformin Hcl | 190 | 15,210 | $1,236.07 | 67 |
| Estradiol (Twice Weekly) | Estradiol | 186 | 8,261 | $13,559.64 | 50 |
| Finasteride | Finasteride | 183 | 14,730 | $3,426.42 | 60 |
| Bicalutamide | Bicalutamide | 125 | 7,055 | $2,793.08 | 48 |
| Celecoxib | Celecoxib | 93 | 5,610 | $1,611.21 | 25 |
| Erleada | Apalutamide | 86 | 3,420 | $1,324,940.62 | 15 |
| Tadalafil | Tadalafil | 67 | 5,310 | $3,954.21 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 64 | 5,760 | $970.21 | 21 |
| Doxazosin Mesylate | Doxazosin Mesylate | 60 | 5,277 | $1,892.96 | 30 |
| Dotti | Estradiol | 51 | 2,661 | $5,350.15 | 22 |
| Abiraterone Acetate | Abiraterone Acetate | 49 | 1,470 | $39,547.93 | — |
| Methylprednisolone | Methylprednisolone | 40 | 291 | $270.72 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 299 | $225.08 | 37 |
| Xtandi | Enzalutamide | 39 | 1,170 | $465,572.33 | — |
| Terazosin Hcl | Terazosin Hcl | 28 | 2,376 | $490.88 | 11 |
| Prednisone | Prednisone | 27 | 1,089 | $153.56 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | 2,250 | $524.57 | — |
| Metformin Hcl Er | Metformin Hcl | 24 | 2,160 | $408.03 | — |
| Ursodiol | Ursodiol | 20 | 592 | $859.16 | — |
| Simvastatin | Simvastatin | 19 | 1,710 | $192.64 | — |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | 1,320 | $587.79 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - RADIATION ONCOLOGY
I20090429000680
FL
3779631817
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated August 31, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Sarasota
- Dr. Thomas Schwartz, MD
- Dr. Jonathan Yunis, MD
- Donna Mathisen, MS, RPT
- Dr. Michael Sassaris, MD
- Dr. Louis Chaykin, MD, FACE
- Dr. Michael Lamensdorf, MD
Mailing Address
2803 Fruitville Rd, Suite 1
Sarasota, FL 342375344
Phone: 9419574926